Shares of Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Free Report) rose 10.7% on Wednesday. The company traded as high as $0.2658 and last traded at $0.2658. Approximately 315 shares traded hands during mid-day trading, a decline of 96% from the average session volume of 8,852 shares. The stock had previously closed at $0.24.
Algernon Pharmaceuticals Stock Down 9.6%
The company has a 50 day simple moving average of $0.31 and a 200-day simple moving average of $0.21.
About Algernon Pharmaceuticals
Algernon Pharmaceuticals is a Canadian clinical-stage pharmaceutical development company focused on researching and developing therapies for unmet medical needs. The company’s strategy has centered on drug repurposing, which involves evaluating previously studied compounds for potential use in new disease indications.
Its research programs have included NP-120, an ifenprodil-based therapy investigated for conditions such as idiopathic pulmonary fibrosis and other serious respiratory diseases.
Read More
- Five stocks we like better than Algernon Pharmaceuticals
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
